Dr Reddys Laboratories (RDY) EBT Margin (2016 - 2025)
Historic EBT Margin for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to 17.68%.
- Dr Reddys Laboratories' EBT Margin fell 47400.0% to 17.68% in Q4 2025 from the same period last year, while for Dec 2025 it was 29.27%, marking a year-over-year decrease of 22500.0%. This contributed to the annual value of 23.62% for FY2025, which is 21200.0% down from last year.
- According to the latest figures from Q4 2025, Dr Reddys Laboratories' EBT Margin is 17.68%, which was down 47400.0% from 23.58% recorded in Q1 2025.
- Dr Reddys Laboratories' 5-year EBT Margin high stood at 28.08% for Q1 2022, and its period low was 0.0% during Q3 2022.
- Over the past 5 years, Dr Reddys Laboratories' median EBT Margin value was 23.4% (recorded in 2024), while the average stood at 20.89%.
- In the last 5 years, Dr Reddys Laboratories' EBT Margin plummeted by -182600bps in 2022 and then soared by 278100bps in 2023.
- Dr Reddys Laboratories' EBT Margin (Quarter) stood at 4.51% in 2021, then skyrocketed by 369bps to 21.12% in 2022, then rose by 22bps to 25.81% in 2023, then fell by -13bps to 22.42% in 2024, then dropped by -21bps to 17.68% in 2025.
- Its last three reported values are 17.68% in Q4 2025, 23.58% for Q1 2025, and 22.42% during Q4 2024.